Lyell Immunopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	60.18	105.6	145.65	123.55	293.83
Short-Term Investments	187.04	264.93	400.58	516.6	320.97
Cash & Short-Term Investments	247.22	370.53	546.22	640.15	614.79
Cash Growth	-33.28%	-32.17%	-14.67%	4.13%	0.36%
Other Current Assets	13.72	9.07	8.46	11.14	11.49
Total Current Assets	260.94	379.59	554.69	651.3	626.29
Net Property, Plant & Equipment	53.64	72.94	142.32	166.27	166.64
Long-Term Investments	19	32.01	48.51	115.04	330.53
Other Long-Term Assets	6.47	6.31	4.52	4.96	3.95
Total Assets	340.05	490.86	750.03	937.56	1,127
Accounts Payable	2.89	5.37	4.82	3.92	3.21
Accrued Expenses	46.52	40.82	28.13	28.76	29.06
Unearned Revenue	-	-	-	-	4.99
Other Current Liabilities	-	7.6	1.58	4.36	9.49
Total Current Liabilities	49.41	53.79	34.52	37.03	46.74
Long-Term Leases	41.92	50.99	56.89	63.17	66.65
Other Long-Term Liabilities	0.52	3.25	3.66	4.11	84.23
Total Long-Term Liabilities	42.44	54.25	60.56	67.28	150.88
Total Liabilities	91.85	108.04	95.08	104.31	197.62
Common Stock	0	0	0.03	0.03	0.02
Additional Paid-in Capital	1,868	1,728	1,657	1,608	1,516
Accumulated Other Comprehensive Income	0.24	0.29	-0.09	-7.6	-1.62
Retained Earnings	-1,620	-1,345	-1,002	-767.48	-584.36
Total Common Shareholders' Equity	248.2	382.82	654.95	833.25	929.79
Shareholders' Equity	248.2	382.82	654.95	833.25	929.79
Total Liabilities & Equity	340.05	490.86	750.03	937.56	1,127
Total Debt	41.92	50.99	56.89	63.17	66.65
Net Cash (Debt)	205.3	319.53	489.33	576.98	548.14
Net Cash Growth	-35.75%	-34.70%	-15.19%	5.26%	-2.41%
Net Cash Per Share	12.01	24.44	38.99	46.70	80.66
Book Value	248.2	382.82	654.95	833.25	929.79
Book Value Per Share	14.52	29.28	52.19	67.45	136.82
Tangible Book Value	248.2	382.82	654.95	833.25	929.79
Tangible Book Value Per Share	14.52	29.28	52.19	67.45	136.82

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q